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A B S T R A C T
Accumulation of senescent cells over time contributes to aging and age-related diseases. However, what drives
senescence in vivo is not clear. Here we used a genetic approach to determine if spontaneous nuclear DNA
damage is suﬃcient to initiate senescence in mammals. Ercc1-/Δ mice with reduced expression of ERCC1-XPF
endonuclease have impaired capacity to repair the nuclear genome. Ercc1-/Δ mice accumulated spontaneous,
oxidative DNA damage more rapidly than wild-type (WT) mice. As a consequence, senescent cells accumulated
more rapidly in Ercc1-/Δ mice compared to repair-competent animals. However, the levels of DNA damage and
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T
Aging senescent cells in Ercc1-/Δ mice never exceeded that observed in old WT mice. Surprisingly, levels of reactive
oxygen species (ROS) were increased in tissues of Ercc1-/Δmice to an extent identical to naturally-aged WT mice.
Increased enzymatic production of ROS and decreased antioxidants contributed to the elevation in oxidative
stress in both Ercc1-/Δ and aged WT mice. Chronic treatment of Ercc1-/Δ mice with the mitochondrial-targeted
radical scavenger XJB-5–131 attenuated oxidative DNA damage, senescence and age-related pathology. Our
ﬁndings indicate that nuclear genotoxic stress arises, at least in part, due to mitochondrial-derived ROS, and this
spontaneous DNA damage is suﬃcient to drive increased levels of ROS, cellular senescence, and the consequent
age-related physiological decline.
1. Introduction
Aging is the primary risk factor for the majority of chronic diseases;
hence, aging is now being considered as a therapeutic target [1].
However, this remains a challenge as the precise molecular mechanisms
underpinning aging are not well deﬁned. Cellular senescence was re-
cently established to play a causal role in aging [2] and many age-
related diseases [3–8]. Senescence is a programmed cell fate char-
acterized by growth arrest, a metabolic shift, resistance to apoptosis
and often a secretory phenotype [9]. The senescent cell burden in-
creases with age in virtually all vertebrates [10–12]. In replicating
human cells, shortened telomeres drive senescence [13]. It has become
increasingly clear that non-replicating cells also undergo senescence
[14]. However, in non-dividing cells, which are the majority of cells in
mammalian organisms, the cause of senescence is not clear.
A variety of cellular stressors including genotoxic, proteotoxic, in-
ﬂammatory and oxidative have been implicated in driving senescence
[9,15]. However, senescence itself is associated with many of these
cellular stressors [16], making it very diﬃcult to decipher cause and
eﬀect. For example, DNA damaging agents deﬁnitively cause increased
senescence (e.g. in cancer patients) [17]. Yet senescent cells are deﬁned
by persistent activation of the DNA damage response [18], increased
expression of surrogate markers of DNA damage [19] and are able to
trigger genotoxic stress in neighboring cells [16]. Therefore, in vivo, the
importance of DNA damage as a driver of senescence and aging is de-
bated [20].
Even less is known about endogenous DNA damage as a potential
driver of senescence and aging. The vast majority of evidence im-
plicating DNA damage in senescence comes from experiments im-
plementing very high doses of environmental genotoxins such as io-
nizing radiation, doxorubicin, etoposide or cisplatin [19,21,22]. Also of
note, all genotoxins damage not only DNA, but also all cellular nu-
cleophiles including phospholipids, proteins and RNA. Thus, it remains
unknown whether physiological levels of spontaneous DNA damage is
suﬃcient to drive cellular senescence.
A major source of endogenous DNA damage is reactive oxygen
species (ROS) produced during mitochondrial-based aerobic metabo-
lism (e.g. the superoxide anion (O2•-) and the hydroxyl radical (•OH)
produced from O2•-or H2O2 via the Fe2+-dependent Fenton or Haber-
Weiss reaction) [23]. The DNA lesions caused by ROS include oxidized
bases, abasic sites, single-strand breaks and lipid peroxidation-induced
adducts such as interstrand crosslinks [24]. Some mitochondrial-de-
rived ROS, such as H2O2, can diﬀuse throughout the cell, resulting in
oxidative damage to lipids, proteins, RNA and DNA [25]. Thus, mi-
tochondrial dysfunction, which leads to an increase in ROS production,
was proposed to be central to the aging process [26,27]. However, this
too remains controversial [28].
To address these gaps in knowledge, we utilized a genetic approach
to increase endogenous nuclear DNA damage in mice. ERCC1-XPF is an
endonuclease complex required for nucleotide excision repair, inter-
strand crosslink repair and the repair of a subset of DNA double-strand
breaks [29]. Mutations that mediate reduced expression of this enzyme
cause accelerated aging in humans and mice [29]. ERCC1 is required to
stabilize XPF in vivo [30]. Therefore, Ercc1-/Δ mice, with one knock-out
and one hypomorphic allele of Ercc1 have 5–10% of the normal
complement of ERCC1-XPF [31]. Genetic depletion of DNA repair me-
chanisms does not increase the amount of damage incurred, it simply
accelerates the pace at which damage triggers a demonstrable physio-
logical impact, aﬀording an opportunity to investigate the role of en-
dogenous nuclear DNA damage in driving senescence.
Here, we demonstrate that Ercc1−/Δ mice accumulate oxidative
DNA damage and senescent cells more rapidly than age-matched wild-
type (WT) controls, yet comparable to WT mice over two years of age.
Surprisingly, we found that Ercc1−/Δ mice are also under increased
oxidative stress. Increased ROS production and decreased antioxidant
buﬀering capacity contributed to the oxidative stress, which was also
observed in aged WT mice. Treatment of Ercc1-/Δ mice with a mi-
tochondrial-targeted radical scavenger (XJB-5–131) was suﬃcient to
suppress oxidative DNA damage, senescence and age-related patholo-
gies. These data demonstrate that damage of the nuclear genome
arising spontaneously in vivo is suﬃcient to drive cellular senescence.
Our data also demonstrate that endogenous DNA damage, as a primary
insult, is able to trigger increased reactive oxygen species (ROS) and
further oxidative damage in vivo.
2. Methods
2.1. Chemicals and reagents
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO)
unless otherwise speciﬁed. Primary antibodies used for immunoblotting
were purchased from Abcam (Cambridge, MA) unless indicated.
2.2. Animal care and experimentation
All animal studies were conducted in compliance with the U.S.
Department of Health and Human Services Guide for the Care and Use
of Laboratory Animals, and were approved by the Scripps Florida or
University of Pittsburgh Institutional Animal Care and Use Committee.
Ercc1-/Δ mice were bred and genotyped as previously described [32].
P16-luciferase reporter mice were obtained from Ohio State University
[10] and bred to create Albino C57BL/6 p16luc/+;Ercc1+/- and FVB/n
p16luc/+;Ercc1+/Δ mice. These mice were further crossed to create f1
p16luc/luc;Ercc1-/Δ mice with white fur for imaging. All animals were
genotyped from an ear punch by TransnetYX (Cordova, TN).
2.3. DNA extraction and measurement of cyclopurine DNA lesions
DNA was isolated using a high-salt extraction method [33] from
cultured MEFs or liver tissue, which was pulverized with a mortar and
pestle under liquid nitrogen. Cyclopurine lesions were measured by LC-
MS/MS/MS using an LTQ linear ion trap mass spectrometer using our
recently described conditions with some modiﬁcations [34]. Nuclease
P1 (0.1 U/μg DNA), phosphodiesterase 2 (0.000125 U/μg DNA), 20
nmol of erythro-9-(2-hydroxy-3-nonyl) adenine EHNA and a 20-μL so-
lution containing 300mM sodium acetate (pH 5.6) and 10mM zinc
chloride were added to isolated nuclear DNA. In this context, EHNA
served as an inhibitor for deamination of 2’-deoxyadenosine to 2'-
deoxyinosine induced by adenine deaminase [34]. The above digestion
mixture was incubated at 37˚C for 48 h. To this mixture were then
A.R. Robinson et al. Redox Biology 17 (2018) 259–273
260
added alkaline phosphatase (0.05 U/μg DNA), phosphodiesterase 1
(0.00025 U/μg DNA) and 40 μL of 0.5M Tris-HCl buﬀer (pH 8.9). The
digestion was continued at 37˚C for 2 h and subsequently neutralized by
addition of formic acid. To the mixture were then added appropriate
amounts of uniformly 15N-labeled standard lesions, which included R-
cdG, S-cdG, R-cdA and S-cdA. The digestion mixture was subsequently
extracted twice with chloroform. The resulting aqueous layer was
subjected to oﬀ-line high performance liquid chromatography (HPLC)
separation for the enrichment of the lesions under study, following our
previously described procedures [34]. The LC-MS/MS/MS experiments
were conducted using an LTQ linear ion trap mass spectrometer using
our recently described conditions with some modiﬁcations [34].
Brieﬂy, a 0.5×150mm Zorbax SB-C18 column (particle size, 5 µm,
Agilent) was used for the separation of the above-enriched lesion
fractions, and the ﬂow rate was 4.0 μL/min. A solution of 0.1% (v/v)
formic acid in water (solution A) and a solution of 0.1% (v/v) formic
acid in methanol (solution B) were used as mobile phases for the ana-
lyses of all four cyclopurine lesions, i.e. the (5′R) and (5′S) diaster-
eomers of cdA and cdG, after HPLC enrichment, and a gradient of 5min
0–20% B, 30min 20–80% B, and 5min 80% B was employed for the
separation.
2.4. Fluorescence in situ hybridization for telomere-speciﬁc γH2AX foci
Primary murine embryonic ﬁbroblasts (MEFs) were ﬁxed with 2%
paraformaldehyde for 15min followed by permeabilization (0.2%
Triton X-100in PBS) for 15min. Cells were then blocked (2% BSA, 20%
goat serum in PBS) for 2 h. Cells were immuno-stained with mouse anti-
γH2AX monoclonal antibody (1:500; Upstate, Billerica, MA) overnight
and goat anti-mouse 594 secondary antibody (1:1000) for 1 h. Cells
were then ﬁxed in 2% paraformaldehyde for 5min. Samples were de-
hydrated in 70%, 95%, 100% ethanol (5min each) and then denatured
for 10min at 80 °C in hybridization solution (70% deionized for-
mamide, 10% NEN blocking reagent [Roche], 0.1M Tris-HCl [pH 7.4],
MgCl2 buﬀer [82mM NaH2PO4, 9mM citric acid, 20mM MgCl2], and
0.5 µg/mL Cy3-OO-(CCCTAA)3 PNA probe (Panagene, South Korea).
After 2 h hybridization at room temperature, the samples were washed
twice with 70% deionized formamide in 10mM Tris-HCl, pH 7.2.
Samples were counterstained with DAPI, mounted onto slides with
Gelvatol and images were acquired with a Nikon A1 confocal micro-
scope (Nikon Instruments, Inc.).
2.5. Senescence-associated β-galactosidase (SA-β-gal) staining of tissue
Fresh tissues were ﬁxed in 10% neutral buﬀered formalin (NBF) for
3–4 h and then transfered to 30% sucrose overnight. Tissues were then
embedded in cryo-embedding media (OCT) and cryosectioned at 6 µm
for SA-β-gal staining (pH 5.8) at 37oC for 16–24 h in SA-β-gal staining
solution (pH 6.0; 40mM citric acid in sodium phosphate buﬀer, 5 mM
K4[Fe(CN)6] 3H2O, 5mM K3[Fe(CN)6], 150mM sodium chloride, 2 mM
magnesium chloride and 1mg/mL X-gal dissolved in N,N-di-
methylformamide).
2.6. IVIS in vivo imaging detection of luciferase activity
Isoﬂurane-anesthetized mice were injected intraperitoneally with D-
luciferin substrate (Caliper Life Sciences, Hopkinton, MA; 15mg/mL in
PBS) and were imaged by using an IVIS Lumina (Caliper Life Sciences)
as previously described [10].
2.7. RNA isolation and qPCR
Tissues were harvested from euthanized animals and snap frozen in
liquid nitrogen. Tissues were homogenized using FastPrep-24 homo-
genizer (MP Biomedicals, Solon, OH) and total RNA was isolated using
Trizol, according to manufacturer’s speciﬁcations (Thermo Fisher,
Waltham, MA). Total RNA was quantiﬁed using a Nanodrop spectro-
photometer (Thermo Fisher) and 1 μg of total RNA was used to generate
cDNA with the Transcriptor First Strand cDNA synthesis kit (Roche,
Basel Switzerland) according to the manufacturer’s speciﬁcation. Gene
expression changes in p16 was quantiﬁed by qPCR reactions using 20 μL
reaction volumes using a StepOne thermocycler (Thermo Fisher) with
input of 100 ng cDNA per reaction. Reactions were performed in du-
plicate (n= 4–12 mice per group). Data was analyzed by ΔΔCt method
and expression was normalized to Gapdh. Primer sequences are as fol-
lows: Cdkn2a (p16) Fwd 5’- CCCAACGCCCCGAACT-3’, Cdkn2a (p16)
Rev 5’- GCAGAAGAGCTGCTACGTGAA-3’; Gapdh Fwd 5’-AAGGTCATC
CCAGAGCTGAA-3’, Gapdh Rev 5’-CTGCTTCACCACCTTCTTGA-3’.
2.8. Biochemical detection of superoxide
Fresh murine tissue slices were incubated in a 30 µM solution of
hydroethidine (HE) in PBS for 45min at 37oC in the dark. The slices
were washed with iced cold PBS and placed into a 1.5mL Eppendorf
tube and immediately frozen by immersion in liquid nitrogen.
Superoxide levels were measured by the presence of 2-hydroxyethidium
(2-OH-E+) using a HPLC system equipped with electrochemical de-
tector as previously reported [35,36]. Brieﬂy, the separation of the
oxidized products of hydroethidine (HE) was performed using an ether-
linked phenyl column (Phenomenex, 100 X 4.6 mm, 2.6 µm) and a
gradient elution method using two mobile phases with an increasing
fraction of acetonitrile (from 25% to 60% over 10min). The presence of
superoxide was also conﬁrmed by electron paramagnetic resonance
(EPR) spectroscopy spin-trapping of a 1-hydroxy-3-methoxy-carbonyl-
2,2,5,5-tetramethylpyrrolidine (CMH) (Noxygen Science Transfer and
Diagnostics, Elzach, Germany) superoxide-sensitive probe and analyzed
using a temperature- and O2-controlled Bruker EPR (Millerica, MA) at
37oC as described [37]. n= 3–9 mice per genotype.
2.9. Immuno-spin trapping of biomolecular free radicals
Brieﬂy, mice were injected with 500mg/kg 5,5-dimethyl-1-pyrro-
line N-oxide (DMPO, Dojindo, Japan) at 24, 12 and 6 h prior to eu-
thanasia. Tissues were ﬁxed in 2% PFA in PBS for 1 h then submerged in
30% sucrose for 24 h, with several solution exchanges. Tissues were
cryopreserved in 2-methylbutane then sectioned on a cryostat (Leica
Biosystems, Richmond, IL). Sections were stained with polyclonal anti-
DMPO (ALX-210–530-R050; Enzo Life Sciences) followed by secondary
antibody (Alexa Fluor 488 anti-rabbit IgG; Life Technologies). Tissues
were counterstained with DAPI to detect nuclei and for actin (ﬂuor-
conjugated phalloidin) to reveal tissue architecture. For liver, 9 x 9
image sections were stitched together from multiple images with 10%
stitching overlap using the Nikon NIS-Elements software. 3–5 mice
were used per group.
2.10. Lipid peroxidation
4-Hydroxynonenal-protein adducts, which are by-products of lipid
peroxidation, were measured in murine liver using the OxiSelect HNE
Adduct Competitive ELISA kit (Cell Biolabs, San Diego, CA). Livers ly-
sates were prepared in RIPA buﬀer and normalized based on protein
concentration. µg of total protein was used for each assay. Four liver
samples were measured in duplicate for each group except old WT mice
(n= 3–4). Measurements were taken using an EnVision plate reader
(Perkin Elmer, Waltham, MA).
2.11. Xanthine oxidase activity
Xanthine oxidase activity was measured as previously described
[38]. Brieﬂy, liver samples (50mg) from 7 to 9 mice per group were
homogenized in ice-cold potassium phosphate buﬀer (50mM, pH 7.4)
and incubated in the presence of 200 µM xanthine and 100 µM oxonic
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acid for 60min at 37oC (with and without 200 µM allopurinol). Accu-
mulation of uric acid over this time (above that observed in the pre-
sence of allopurinol) frame was assessed via reverse phase HPLC cou-
pled to an electrochemical detector (ESA CoulArray, Chelmsford, MA),
(1 Unit = 1 µmole urate/min). Similarly, XO activity was measured
from the serum of mice (n= 3–9).
2.12. NADPH oxidase activity
Tissue O2•- production was calculated from the initial linear rate of
SOD-sensitive cytochrome c reduction quantiﬁed at λ=550 nm.
Brieﬂy, homogenates of frozen liver samples were resuspended in
Oxidase Assay Buﬀer (65mM sodium phosphate buﬀer (pH 7.0), 1 mM
EGTA, 10 μM FAD, 1mM MgCl2, 2 mM NaN3, 300 U/mL catalase, and
0.2 mM cytochrome c), in the presence or absence of superoxide dis-
mutase (150 U/mL). After 5min baseline measurement, NADPH
(180 μM) was added and O2•- production was measured at 550 nm using
a Biotek Synergy 4 hybrid multimode microplate reader. 6–13 mice per
group were used. Data are expressed as fold change from WT.
2.13. Mitochondrial respiration
Mitochondrial respiration in isolated liver mitochondria was mea-
sured by the oxygen consumption rate (OCR) using a Seahorse XF96
Extracellular Flux Analyzer (Agilent Seahorse, Santa Clara, CA). Liver
mitochondria were isolated as described [39]. 150 μL suspension of
liver mitochondria (6 µg protein/well) was plated on a pre-chilled
Seahorse PS 96-well microplate reader. The plate was centrifuged at
3220×g for 50min at 4 °C, subsequently incubated in 37 °C (without
CO2) for 15min then transferred to the XF ﬂux analyzer for respiration
measurement. The measurement cycle consisted of a 3min mixing time
and a 4min time point. After three basal measurements in the presence
of complex I substrate pyruvate (5 mM), 150 μM ADP, 2 µg/mL oligo-
mycin (inhibitor of ATP synthase), 4 µM carbonylcyanide p-tri-
ﬂuoromethoxyphenylhydrazone (FCCP; an optimized concentration to
give maximum respiratory capacity), 2 µM rotenone and 2 µg/mL an-
timycin A were auto-injected into the experimental wells, and another
three measurement cycles were performed. Each experimental point is
an average of a minimum of three replicate wells on four mice per
group. State III and maximal respiration were calculated as described
[40].
2.14. Metabolite extraction
Liver samples were weighed (10mg) from 12-week-old WT (n=7),
old WT (120–136-week-old) (n= 7) and 12-week-old Ercc1-/Δ (n= 6)
mice. Samples were homogenized in 400 μL methanol/water (80:20 v/
v) with 1mm glass beads (Biospec, Bartlesville, OK, USA) in 1.5 mL
glass vials. A Minilyse homogenizer (Bertin Technologies, Montigny le
Bretonneux, France) was used for 30 s at 3000 rpm. The samples were
sonicated for 15min and stored overnight at -20oC. The samples were
centrifuged at 15,000×g for 15min at 4oC. The supernatant was
transferred to 1.5 mL glass vials and stored at -20oC until later use. The
pellet was resuspended in 600 μL acetone and homogenized again for
10 s, and stored at -20oC overnight. The samples were centrifuged at
15,000×g for 15min at 4oC and the supernatant pooled with pre-
viously retained supernatant. The samples were dried down in a
speedvac and resuspended in 100 μL acetonitrile/water (50/50 v/v),
sonicated for 5min, centrifuged for 15min at 15,000×g, 4oC and
transferred to autosampler vials for storage at -80oC until use.
2.15. Global metabolomic analysis
Analyses were performed using a high-performance liquid chro-
matography (HPLC) system (1200 series, Agilent Technologies) coupled
to a 6550 ifunnel quadrupole time-of-ﬂight (Q-TOF) mass spectrometer
(Agilent Technologies). Samples were injected (8 μL) onto a Luna
Aminopropyl, 3 µm, 150mm×1.0mm I.D. column (Phenomenex,
Torrance, CA) for hydrophilic interaction liquid chromatography
(HILIC) analysis. Pooled samples were injected every three samples and
a blank after every samples for quality control. The standard mobile
phase was A =20mM ammonium acetate and 40mM ammonium hy-
droxide in 95% water and B =95% acetonitrile in ESI negative mode.
The linear gradient elution from 100% B (0–5min) to 100% A
(50–55min) was applied at a ﬂow rate of 50 μL/min with a 10min post-
run. ESI source conditions were set as following: gas temperature 200˚C,
drying gas 11 L/min, nebulizer 15 psig, sheath gas temperature 300˚C,
sheath gas ﬂow 9 l/min, fragmentor 360 V, nozzle voltage 500 V, and
capillary voltage 2500 V. The instrument was set to acquire over the m/
z range 60–1200, with the MS acquisition rate of 2 spectra/s. For the
MS/MS of selected precursors the default isolation width was set as
medium (~4m/z), with a MS acquisition rate at 3 spectra/s and MS/MS
acquisition at 3 spectra/s. The collision energy was ﬁxed at 20 eV. LC/
MS data were processed using XCMS Online [41]. Unpaired parametric
tests were carried out. Features were listed in a feature list table and as
an interactive cloud plot, containing their integrated intensities (ex-
tracted ion chromatographic peak areas) observed fold changes across
the two sample groups, and p-values for each sample [42]. Integration
of METLIN to XCMS Online allowed for putative identiﬁcation of me-
tabolites. Identiﬁcations were then made by comparing retention times
and tandem MS fragmentation patterns to the sample and standard
compounds (purchased from Sigma Aldrich, St. Louis, MO).
2.16. Liver proteomic analysis
Male CB6f1, C57BL/6 and female C57BL/6: FVB f1 WT livers were
harvested at 5–8 months and 30–32 months, as well as male and female
C57BL/6: FVB F1 Ercc1−/Δ livers at 4 months (n= 4–8). Livers were
homogenized in 125mM Tris-HCl, pH 7.6, using a MP Biomedicals Fast
Prep 24, Lysing Matrix D. Lysates were brought to 100mM Tris-HCl, pH
7.6, 4% sodium dodecyl sulfate, and 100mM dithiothreitol and heated
to 99˚C for 5min. Cooled samples were protein assayed using 660 nm
Protein Assay with Ionic Detergent Compatibility Reagent (Pierce,
Rockford, IL). Equal protein amounts were dialyzed, alkylated, and
digested using the FASP methodology [43,44]. Brieﬂy, samples were
buﬀer exchanged into 8M Urea, alkylated with 20mM iodoacetamide,
buﬀer exchanged into ammonium bicarbonate, and digested with mass
spec sequencing grade trypsin (Promega, Madison, WI) in a Millipore
Microcon Ultracel YM-30 microcentrifuge ﬁlter [45]. Collected peptides
were desalted using Discovery DSC-18 vacuum manifold columns with
a 50mg bed weight (Supelco, Bellefonte, PA) [46]. Desalted peptides
were dried down in a centrifugal concentrator with inline cold trap
(Labconco, Kansas City, MO) [47]. Desalted peptides were resuspended
at 1mg/mL in 0.1% formic acid in mass spectrometry grade water
(Burdick & Jackson, Muskegon, MI).
Desalted peptides were separated across a hydrophobicity gradient
of 3–32% acetonitrile over 60min at 300 nL/min using a Waters
NanoACQUITY (ultra-high pressure liquid chromatography) UPLC on a
25 cm, 75 µm ID, 5 µM reversed phase C18 heated PicoChip column
(New Objective) in line with a high resolution Fourier transform
Orbitrap XL mass spectrometer (Thermo Fisher Scientiﬁc). A top 4 data
dependent acquisition was employed with a 60,000 resolution full scan
and four subsequent low resolution MS/MS identiﬁcation scans per-
formed in the ion trap.
Mass spectrometric raw ﬁles were translated and analyzed using the
CHORUS cloud computing label free quantitation analysis suite (chor-
usproject.org). Brieﬂy, chromatographic peaks, features, are separated
from noise and placed into appropriate isotope groups before alignment
across all samples and quantiﬁcation using label free diﬀerential mass
spectrometry [48,49]. Identiﬁcation is performed using the Comet and
Percolator MS/MS identiﬁcation engines compared to the Uniprot re-
ference data set for Mus musculus, generating identiﬁcation and
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quantiﬁcation data for all features [50,51].
Statistical analysis was performed on all identiﬁed features by re-
jecting any feature not found in at least 75% of samples following
outlier removal. Feature level data was brought to protein level by
taking the median level of all unmodiﬁed, unique peptides of a given
protein per sample, with a minimum of two unique peptides per pro-
tein. A two-tailed Student’s t-test was performed to establish statistical
signiﬁcance for all proteins identiﬁed.
(caption on next page)
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2.17. Catalase activity
Catalase activity in liver tissue was determined as previously re-
ported [52]. 50 μg of liver lysate from each mouse were used and
analyzed in duplicate. Detection of peroxide (Fisher Scientiﬁc, Pitts-
burgh, PA) at 240 nm was performed using a Cary 300 BIO UV–VIS
spectrophotometer (Varian, Palo Alto, CA) at 30 s intervals for a total of
1min. Catalase activity per milligram of protein (k/mg) was quantiﬁed
using the following formula: k/mg = [3 ln (Absinitial/Absﬁnal)] /[milli-
grams of protein * time] with 3–5 mice were used per group.
2.18. Superoxide dismutase activity
SOD activity (mitochondrial and cytoplasmic) was quantiﬁed using
the Superoxide Dismutase Assay Kit (Cayman) per the manufacturer’s
instructions. All liver samples were normalized based on protein con-
centration with n=3 per group.
2.19. Glutathione analysis
Livers were harvested from euthanized mice, ﬁxed in 5% sulfosa-
licylic acid and extracts were prepared by homogenization in MES
buﬀer (0.2M 2-(N-morpholino) ethanesulphonic acid, 0.05M phos-
phate and 1mM EDTA, pH 6.0) to prevent post-mortem oxidation of
glutathione [53]). Samples were normalized by protein concentration
and analyzed for concentration of total GSH and GSSG using a Glu-
tathione Assay Kit (Cayman Chemicals, Ann Arbor, MI) per the manu-
facturer’s speciﬁcations. Sample absorbance was measured at 405 nm
using a plate reader. Equation to determine reduced GSH was [Reduced
GSH] = [Total GSH]-[GSSG], and ratio was reported as [Reduced
GSH]/[GSSG] [54]. n= 3–14 mice per age/genotype.
2.20. Immunoblotting
Liver and kidney samples from 18-week-old Ercc1−/Δ and WT mice
(n=5) were homogenized in RIPA buﬀer (Pierce, Rockford, IL) with
protease inhibitor cocktail (Roche, Indianapolis, IN). Mitochondrial
extracts were prepared using Mitochondria Isolation Kit (Pierce) per the
manufacturer’s speciﬁcations. Samples were separated on 4–20%
polyacrylamide gel (Bio-Rad, Hercules, CA), transferred to ni-
trocellulose membrane, blocked and blotted with anti-PCNA (PC10,
Santa Cruz Biotechnology, Santa Cruz, CA), anti-ERCC1 (D-10, Santa
Cruz Biotechnology), anti-COXIV (Abcam, Cambridge, MA), anti-XPF
(SPM228, Novus Biologicals, Littleton, CO) or anti-GAPDH, anti-
MnSOD, anti-CuZnSOD, anti-catalase (3H3L29), anti-XO, and anti-
rabbit secondary (all from Life Technologies, Carlsbad, CA) then vi-
sualized with ECL reagent (Pierce). Films exposed to membrane were
imaged with ImageJ (NIH, Bethesda, MD). GAPDH was used as a
loading control.
2.21. Chronic treatment of mice with XJB-5–131
The Ercc1-/Δ mice were given intraperitoneal injections of 2mg/kg
XJB dissolved in sunﬂower oil (S5007 Sigma-Aldrich, St. Louis, MO) or
an equal volume of vehicle only (sunﬂower oil) three times per week,
beginning at ﬁve weeks of age, by an investigator blinded to the
treatment group. Whenever possible, littermate pairs of Ercc1-/Δ mice
were used, with one mouse in each treatment group, to minimize
variability. The mice were weighed twice a week and monitored for the
onset of age-related symptoms, including dystonia, trembling, ataxia,
priapism and urinary incontinence (neurodegenerative symptoms),
hind-limb muscle wasting, lethargy (reduced spontaneous activity) and
kyphosis (hunched posture). Data from littermate pairs were evaluated
to determine the fraction of symptoms delayed in the mouse treated
with XJB vs. its sibling treated with vehicle only using a paired
Student’s t-test. All mice were euthanized at 20 weeks of age and their
tissues were isolated for pathological analysis.
2.22. Micro-computed tomography measurement of bone density
μCT of spines was acquired as previously described [55] using a
VivaCT 40 (Scanco USA Inc.) with 15-μm isotropic voxel size resolution,
55 kVp of energy, and 145 μA of current. After the acquisition of
transverse 2-dimensional image slices, 3-dimensional reconstruction of
the lumbar vertebrae was performed using a constant threshold value of
235, which was selected manually for the bone voxels by visually
matching the threshold areas to the gray-scale images.
2.23. Statistics
The mean and standard deviation or standard error of the mean
were calculated for all experimental groups and analyzed using un-
paired two-tailed Student’s t-tests, or one-way or two-way ANOVA or
Tukey's test for multiple comparisons using GraphPad Prism 6.
3. Results
3.1. Ercc1−/Δ mice have accelerated accumulation of spontaneous
oxidative DNA damage
To test conventional wisdom that nucleotide excision repair (NER)
is exclusively nuclear and not a mitochondrial DNA repair mechanism
[56], ERCC1 and XPF protein levels were measured in fractionated
murine liver lysates (Fig. 1A). Both proteins were detected in the nu-
clear but not mitochondrial fractions, establishing their role in pro-
tecting the nuclear genome, exclusively. Cyclopurines (cPus) are DNA
lesions generated by endogenous reactive oxygen species [57], which
are repaired by NER [58]. Thus, cPus are expected to be increased in
Ercc1−/Δ mice compared to age-matched WT animals. LC-MS/MS/MS
was used to measure the four cPus lesions (R-cdG, S-cdG, R-cdA and S-
cdA) in kidney tissue of mice (Supplemental Fig. 1) [59]. At two months
of age, the levels of cPu were not elevated in Ercc1−/Δ mice (Fig. 1B).
By ﬁve months of age, however, all four lesions were signiﬁcantly in-
creased in Ercc1−/Δ compared to WT mice. Notably, S-cdG, R-cdA and
S-cdA also were signiﬁcantly increased in old WT mice compared to
young animals. Furthermore, adduct levels were equivalent in 5-month-
old Ercc1−/Δ and 3-year-old WT mice. This indicates that Ercc1−/Δmice
have an increased burden of endogenous DNA damage than age-
Fig. 1. DNA repair deﬁcient Ercc1-/Δ mice accumulate oxidative damage and senescent cells faster than WT mice. (a) Immunoblot detection of ERCC1 and XPF in
fractionated liver lysates from two WT mice. COXIV was used as a loading control for the mitochondria (Mito) and PCNA was used for the nuclear (Nuc) fraction. (b)
Levels of 8,5’-cyclopurine-2’-deoxynucleosides in DNA isolated from murine kidney. Graphed are the mean and SD from n=3 mice per group. *p < 0.05,
**p < 0.01, ***p < 0.001 calculated by two-way ANOVA. Data are derived from Wang et al. [59]. (c) Staining for SA-β-gal activity on kidney and liver from
Ercc1-/Δ mice and aged WT mice compared to adult WT mice. Images were captured at 20X magniﬁcation. (d) Representative images of p16-luciferase signal in age-
matched WT and a DNA repair-deﬁcient mouse. (e) Total body luciferase activity in p16luc/luc;Ercc1-/Δ (blue) and p16luc/luc (red) mice with increasing age. Dots
represent individual animals. Black bars indicate the mean± standard deviation. p values were calculated using a two-way ANOVA. ***p < 0.001,
****p < 0.0001. * over the blue dots indicate signiﬁcant diﬀerences between the WT and Ercc1-/Δ mice. * over the black bars indicate a signiﬁcant diﬀerence
between Ercc1-/Δ of diﬀerent age groups. (f) qPCR detection of p16Ink4a expression in liver (n= 6–12), kidney (n=4–6) and spleen (n= 7–10) of Ercc1-/Δ mice
(blue), age-matched WT mice (red) and old WT mice (green). Values represent the mean± SD, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
determined by one-way ANOVA with Tukey's test.
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matched repair-proﬁcient animals and that they accumulate sponta-
neous DNA damage faster than WT animals.
3.2. Ercc1−/Δ mice have accelerated accumulation of senescent cells
To determine if endogenous DNA damage is suﬃcient to drive cel-
lular senescence in vivo, multiple markers of senescence were measured
in tissues of Ercc1-/Δ and WT mice of various ages. Senescence-asso-
ciated β− galactosidase (SA-β-gal) activity was increased in 5-month-
old Ercc1-/Δ mouse kidney and liver compared to WT littermates
(Fig. 1C). Two-year-old WT mice also had increased SA-β-gal activity in
these tissues relative to young animals. The level of p16Ink4a expression
was measured using a p16Ink4a-luciferase transgenic reporter (Fig. 1D)
[10]. Total p16Ink4a-luciferase expression was modestly but signiﬁcantly
increased in mutant animals at weaning (Fig. 1E). The signal increased
steadily as the mutant animals aged, in particular, after 8 weeks of age.
Notably, the signal level seen in the DNA repair-deﬁcient mice did not
exceed that of older WT mice. As both WT and Ercc1-/Δ mice aged, the
heterogeneity in signal between animals increased dramatically, as
previously reported for WT mice in a diﬀerent genetic background [10].
Increased p16Ink4a expression was validated by qPCR (Fig. 1F).
p16Ink4a mRNA was signiﬁcantly greater in the liver, kidney and spleen
of Ercc1-/Δ mice compared to WT age-matched controls. p16Ink4a ex-
pression in 3–4 month-old Ercc1-/Δ mice was comparable to that of 2-
year-old WT mice. Taken together, these data document the premature
accumulation of senescent cells in DNA repair-deﬁcient Ercc1-/Δ mice.
Importantly, ERCC1-XPF-deﬁcient human and murine cells do not show
accelerated telomere attrition [60]. To conﬁrm the absence of telomere
dysfunction, we measured telomere damage-induced foci [61] in
Ercc1-/- and WT mouse embryonic ﬁbroblasts (Supplemental Fig. 2).
Notably, the number of γH2AX foci was signiﬁcantly increased in
Ercc1-/- cells compared to WT, as expected for DNA repair-deﬁcient
cells. However, γH2AX foci at telomeric DNA was signiﬁcantly lower in
Ercc1-/- cells, conﬁrming prior studies [60]. These data rule-out telo-
mere dysfunction as the driver of senescence in the absence of ERCC1-
XPF. This suggests that it is unrepaired, endogenous DNA damage that
drives cellular senescence in mammalian tissues.
3.3. Ercc1-/Δ mice demonstrate elevated ROS abundance
The presumption is that Ercc1-/Δmice have increased oxidative DNA
damage because of their defect in NER. However, it is also possible that
Ercc1-/Δ mice are under increased oxidative stress. To test this, we
measured cPus in liver tissue of age-matched Ercc1-/Δ, WT and Xpa-/-
mice. The latter are completely deﬁcient in nucleotide excision repair of
cyclopurine (cPu) lesions. Xpa-/- mice also show no signs of accelerated
aging [62]. Notably, all four cPus were signiﬁcantly elevated in liver of
Ercc1-/Δ mice compared to WT, but cPus were not elevated in Xpa-/-
mouse liver (Fig. 2A). This indicates that lack of DNA repair does not
adequately explain the increased oxidative DNA damage in Ercc1-/Δ
mice.
To determine if the Ercc1-/Δ mice are under increased oxidative
stress, superoxide anion (O2•-) production was measured in fresh renal
and liver tissue by quantiﬁcation of 2-OH-E+. Oxidation of hydro-
ethidine to its O2•--speciﬁc product, 2-hydroxyethidium (2-OH-E+) was
assessed by HPLC coupled to electrochemical detection and validated
by electron paramagnetic resonance (EPR) spin trapping [36].
Superoxide levels were indeed signiﬁcantly greater in Ercc1−/Δ mouse
tissue compared to age-matched controls (Fig. 2B). Interestingly, O2•-
levels were equivalent in 4–5-month-old Ercc1−/Δ and 24–30-month-
old WT mice, extending the parallels between normal and accelerated
aging.
The presence of elevated endogenous ROS levels was conﬁrmed
using a second, in vivo method whereby free radicals are detected by
immuno-spin trapping with the nitrone EPR spin trap 5,5-dimethyl-1-
pyrroline-N-oxide (DMPO). Renal and liver tissue of 5-month-old
Ercc1-/Δ mice had increased DMPO adducts compared to age-matched
WT mice (Fig. 2C and Supplemental Fig. 3). Similarly, DMPO signal
intensity was elevated in naturally aged WT mouse liver and kidney
compared to 5-month-old WT mice.
As a product of lipid peroxidation, 4-hydroxy-2-nonenal (HNE)
chemically modiﬁes proteins and DNA [63] and thus is frequently used
as a measure of oxidative stress [64]. HNE-protein adducts were sig-
niﬁcantly elevated in liver lysates of Ercc1−/Δ and old WT mice com-
pared to young adult WT mice (Fig. 2D). Cumulatively, these data
provide multiple lines of evidence that Ercc1−/Δ mice are under in-
creased oxidative stress, analogous to what occurs with normal aging.
3.4. Increased ROS production as a source of oxidative stress
We next examined potential source(s) of increased ROS abundance.
The enzymatic activity of xanthine oxidase (XO), a key endogenous
enzymatic a source of O2•- and H2O2 [65], was signiﬁcantly increased in
the liver of 4-month-old Ercc1−/Δ mice compared to age-matched WT
animals (Fig. 3A). Aged WT mice also demonstrated elevated liver XO
activity as previously reported [66]. Notably, XO activity was similar in
the progeroid and aged WT mice. Ercc1−/Δ mice also demonstrated
elevated serum XO activity compared to WT littermate controls
(Fig. 3B). The activity of circulating XO was not elevated at 1 month of
age but was increased by 3 months when the mice display aging phe-
notypes [55]. XO activity was not signiﬁcantly increased in serum of
aged WT mice, in contrast to a previous report [66]. NADPH oxidase
(NOX) activity, another key endogenous source of O2•- and H2O2, was
signiﬁcantly elevated in the liver tissue of Ercc1−/Δ and old WT mice
compared to young WT animals (Fig. 3C). These data indicate that the
enhanced O2•- levels detected in liver and kidney of the progeroid and
aged WT mice is likely caused, at least in part, by increased enzymatic
production.
In addition, a shift towards increased oxidative phosphorylation and
oxygen consumption has been reported with aging [67], which is an-
other potential source of increase O2•- production [68]. To determine if
this was also the case in the progeroid Ercc1-/Δ mice, we measured
mitochondrial respiration in organelles isolated from the liver of adult
mutant mice and their littermate controls (Fig. 3D). Indeed, ADP-sti-
mulated respiration and maximum respiration was signiﬁcantly higher
in the Ercc1−/Δ mice compared to age-matched controls; consistent
with previous ﬁndings in cells from DNA repair-deﬁcient mice [69].
This metabolic shift could serve as another source of increased O2•-
production by mitochondria [70].
3.5. Decreased antioxidant activity and levels contribute to excess ROS
Several approaches were used to measure antioxidant status of
progeroid and aged mice. Untargeted mass spectrometry (MS)-based
Fig. 2. Increased oxidative stress in tissues of progeroid Ercc1-/Δ mice and old WT mice. (a) Levels of four cyclopurine lesions (R-cdG, S-cdG, R-cdA, S-cdA) measured
in liver tissues of 4-month-old WT, Xpa-/- and Ercc1-/Δ mice (n= 3 per genotype) by LC-MS/MS/MS. (b) Detection of endogenous superoxide production by
quantifying 2-OH-E+ by HPLC/electrochemical analysis in DHE-treated kidney (n= 3–7) and liver (n= 6–9 animals per genotype/age). (c) Representative images
from immuno-spin trapping of endogenous, biomolecular free radicals with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO). The level of oxidant stress was determined by
immunodetection of DMPO-adducted biomolecules in renal and liver sections. DMPO staining is illustrated in red, actin in green to illustrate tissue architecture and
DAPI in blue to highlight cell nuclei. (d) Lipid peroxidation as measured by quantitation of 4-hydroxynonenal protein adducts via ELISA (n=3–4 mice per group).
For all panels, values represent the mean± SD, *p < 0.05, **p < 0.01, ***p < 0.001 determined by one-way ANOVA with Tukey's test.
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metabolomics on liver extracts comparing 3-month-old WT and Ercc1−/
Δ mice revealed 7935 aligned features, of which 118 were signiﬁcantly
changed between the two groups. Comparison of liver tissues from 3-
month-old and 2.5-year-old WT mice revealed 6812 aligned features, of
which 69 were signiﬁcantly changed between the two groups.
Metabolites were identiﬁed from both analyses using a combination of
MS/MS with spectrum matching on the METLIN database, and con-
ﬁrmed using authentic standards. One of the key nodes identiﬁed by
metabolomics as signiﬁcantly altered with accelerated and normal
aging was glutathione metabolism (Fig. 4A), a key antioxidant and
index of oxidative stress [71].
Diﬀerential MS was used for proteomics analysis to identify redox-
related proteins signiﬁcantly altered in the livers of 3–4 month-old
progeroid Ercc1−/Δ mice and old WT mice (> 2 years-old) vs. adult WT
mice. Expression of catalase, SOD1 (CuZnSOD) and SOD2 (MnSOD)
were signiﬁcantly reduced in Ercc1−/Δ and old WT mice compared to
young adult WT mice (Fig. 4B). In fact, numerous proteins aﬀecting
redox status were identiﬁed as altered in mutant mice, including aco-
nitase 1, cytochrome c oxidase, ATP citrate lyase and microsomal glu-
tathione s-transferase 1 (Supplemental Fig. 4). A very similar pattern of
expression changes occurred in old WT mice, relative to younger ani-
mals. The MS data were validated by immunodetection of several an-
tioxidants by immunoblot (Supplemental Fig. 5).
To validate the predictions arising from the omics studies, activity
of key antioxidants was measured. In liver tissue, catalase activity was
signiﬁcantly decreased in Ercc1−/Δ mice compared to age-matched
controls (Fig. 4C). Interestingly, in young mutant animals (1 month-
old), catalase activity was normal, but then declined progressively over
the rest of their lifespan, reaching a level in the 4–6 month-old Ercc1−/Δ
mice comparable to that of 2.5-year-old WT mice. SOD1 (CuZnSOD-
cytosolic) and SOD2 (MnSOD-mitochondrial) activity in Ercc1−/Δ was
similar to WT mice until they reached 4–5 months of age whereby the
enzymatic activity of CuSOD and MnSOD were signiﬁcantly lower than
that of age-matched controls (Fig. 4D-E). Similarly, MnSOD activity was
lower in 2.5-year-old WT animals (Fig. 4E).
The reduced form of glutathione (GSH) is the active antioxidant and
becomes oxidized to glutathione disulﬁde (GSSG). A decreased ratio of
GSH/GSSG is indicative of a state of oxidative stress as well as anti-
oxidant depletion. The GSH/GSSG was signiﬁcantly reduced in 2
month-old Ercc1−/Δ mice compared to age-matched controls and in-
creased further by 5 months of age (Fig. 4F). In WT mice, the GSH/
GSSG ratio was signiﬁcantly decreased at one year of age compared to
younger animals, then diminished further by 2 years of age, as pre-
viously reported in numerous tissues of rodents [72]. These data pro-
vide multiple lines of evidence indicating that, in addition to increased
ROS production, there is a signiﬁcant decline in antioxidant buﬀering
capacity in Ercc1−/Δ mice, likely contributing to the enhanced levels of
O2•- detected in liver and kidney of the progeroid mice. The parallels
between the Ercc1−/Δ mice and aged WT mice suggest a role for
spontaneous DNA damage and ROS in normal aging as well.
3.6. A mitochondrial-targeted radical scavenger suppresses senescence
To determine if the increased oxidative stress plays a causal role in
driving senescence, Ercc1-/Δ mice were treated with the mitochondrial-
targeted free radical scavenger XJB-5–131. XJB-5–131 is a conjugate
between the nitroxide TEMPO (2,2,6,6-tetramethylpiperidine-1-oxyl)
and the mitochondrial-targeting moiety gramicidin S (Supplemental
Fig. 6A) [73]. TEMPO, a stable free radical, is a potent antioxidant due
to its proclivity for mimicking SOD in vitro. XJB-5–131 has several
advantages over other classes of antioxidants, including its capacity to
recycle (Supplemental Fig. 6B), direct acceptance of electrons from the
mitochondria respiratory complexes to prevent production of ROS, plus
SOD-, catalase- and peroxidase-mimetic activities to neutralize existing
Fig. 3. Increased production of ROS in progeroid Ercc1-/Δ mice and old WT mice. Xanthine oxidase (XO) activity was measured in the (a) livers (n= 7–9 per group)
and (b) serum of Ercc1−/Δ and WT mice (n= 3–4 per group) at multiple ages. (c) NADPH oxidase activity was measured in the livers of 4-month-old Ercc1−/Δ and
WT mice as well as 24-month-old aged WT mice (n= 6–13 per group). (d) Measurement of mitochondrial respiration using a Seahorse Bioscience XF Analyzer on
mitochondria isolated from liver tissues of 2 month-old Ercc1−/Δ and WT mice (n= 4 per group). Values represent the mean± SD, *p < 0.05, **p < 0.01 as
determined by one-way ANOVA with Tukey's test or unpaired two-tailed Student’s t-test.
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ROS [73–75]. XJB-5–131 localizes to mitochondria within 1 h in pri-
mary cell cultures [76] and is enriched 600-fold in the mitochondria
fraction of cells over the cytosol [77,78].
Ercc1-/Δ mice were treated with 2mg/kg XJB-5–131 or vehicle
control, delivered by intraperitoneal injection beginning at 5 weeks of
age (Fig. 5A). Chronic exposure of Ercc1-/Δ mice to XJB-5–131 sig-
niﬁcantly reduced the levels of cPus oxidative DNA lesions in liver
tissue (Fig. 5B). XJB-5–131 also suppressed the accumulation of se-
nescent cells. SA-β-gal staining was reduced in the liver of Ercc1-/Δmice
treated with XJB-5–131 (Fig. 5C). Similarly, XJB-5–131 signiﬁcantly
reduced the luciferase signal in Ercc1-/Δ;p16Ink4a-luciferase reporter
mice (Fig. 5D). Taken together, these results implicate mitochondria-
derived ROS as driving endogenous DNA damage and senescence in
vivo.
3.7. A mitochondrial-targeted radical scavenger suppresses aging symptoms
and pathology
XJB-5–131-treated mice were monitored daily for the onset of
progeroid symptoms by an investigator blinded to the treatment groups.
Mice treated with XJB-5–131 exhibited a signiﬁcant delay in the onset
of dystonia and ataxia, as well as kyphosis, reduced spontaneous ac-
tivity and hind-limb muscle wasting (Table 1 and Fig. 5E). Seventy
percent of the age-related symptoms measured were signiﬁcantly de-
layed in the Ercc1-/Δ mice treated with XJB-5–131 compared to their
vehicle-treated controls. A sixth symptom (urinary incontinence) was
not observed in the 6 male mice in the treatment group, but was seen in
2 of 5 males in the vehicle-only group. XJB-5–131 treatment delayed
the onset of symptoms by 1–2 weeks in Ercc1-/Δ mice which is
equivalent to 5–8 years in humans, based on a median lifespan of 84
years.
Mice from both treatment groups were euthanized at 20 wks of age
for histopathological analyses. At this age, Ercc1-/Δ mice display sig-
niﬁcant levels of age-related hepatic lesions including necrosis and
ballooning degeneration [79]. Both lesions were reduced in Ercc1-/Δ
mice treated with XJB-5–131 compared to those treated with vehicle
only (Fig. 5F). Age-related changes in the kidney, including hyaline
casts, glomerular and tubule-interstitial injury and inﬂammation were
attenuated by XJB-5–131. The drug also delayed the loss of pancreatic
islets in Ercc1-/Δ mice. The brains of XJB-5–131 treated mice showed
reduced staining for glial ﬁbrillary acidic protein (GFAP), a marker of
neurodegeneration (Fig. 5G). Finally, microcomputed tomography of
the spine revealed a signiﬁcant reduction in osteoporotic changes in
Ercc1-/Δ mice treated with XJB-5–131 (Fig. 5H and Supplemental
Fig. 7). This demonstrates that a mitochondrial-targeted radical sca-
venger is suﬃcient to attenuate endogenous oxidative DNA damage,
cellular senescence and aging.
4. Discussion
Although cellular senescence has been demonstrated to drive aging
[2], it is not known what endogenous processes are primarily re-
sponsible for causing cellular senescence in mammals, particularly in
post-mitotic tissues. Here, we used mice in which DNA repair was at-
tenuated genetically. By deﬁnition, the primary insult in untreated
Ercc1-/Δ mice is unrepaired endogenous DNA damage to the nuclear
genome. Not surprisingly, the Ercc1-/Δ mice accumulate senescent cells
more rapidly than WT mice. This formally demonstrates that physio-
logically-relevant types and levels of endogenous DNA damage are able
to trigger the time-dependent accumulation of senescent cells.
The surprising discovery is that there is increased ROS in tissues of
the Ercc1-/Δ mice. This reveals that spontaneous, endogenous nuclear
DNA damage can instigate oxidative stress. We found that elevated ROS
is likely due, at least in part, to increased enzymatic production by
xanthine oxidase (XO) and NADPH oxidase (NOX), altered mitochon-
drial metabolism, as well as an attrition of the expression and activity of
several key antioxidants, catalase, MnSOD and glutathione. Similar
events were found in aged WT mice, consistent with prior studies
[80–83]. The dramatic parallels between the progeroid and naturally
aged mice suggest that oxidative stress is an important common de-
nominator in aging.
To determine if this oxidative stress is pathological, we suppressed it
pharmacologically in Ercc1-/Δ mice with the mitochondrial-targeted
radical scavenger XJB-5–131. Chronic administration XJB-5–131 sig-
niﬁcantly reduced both oxidative DNA damage and senescence (Fig. 5).
The reduced level of senescent cells corresponded to a reduction in age-
related morbidity. This is consistent with numerous recent studies de-
monstrating that genetic or pharmacologic elimination of senescent
cells slows age-related decline [2,4,7,8,84–86]. The observation that
suppressing oxidant production is suﬃcient to decreases senescence
indicates that reactive species are required to ultimately cause or
maintain senescence in response to genotoxic stress.
Analogous to our work, recent studies demonstrated increased NOX
activity in cells from patients with genome instability disorders such as
ataxia telangiectasia (AT) and Nijmegen breakage syndrome [87], as
well as Atm-/- mice [88] that model AT. Interestingly, in worms, NOX
triggers transcriptional activation of stress response mechanisms [89].
Indeed, increased ROS in Atm-/- mice appears to be pathological [88,90]
as well as a critical signaling mechanism both up and downstream of
ATM [91–93]. Increased ROS has also been reported in cells from
xeroderma pigmentosum and Cockayne syndrome patients [94,95], two
diseases caused by a defect in nucleotide excision repair, but the source
of ROS is unclear.
Our results are consistent with the oxidative stress theory of aging
originally proposed by Denham Harman [26], and the notion that a
vicious cycle of ROS generation and oxidative damage is the ultimate
driver of aging [27]. Our data also indicate that endogenous nuclear
DNA damage is able to trigger this cycle of escalating ROS abundance,
oxidative damage, senescent cell accumulation and age-related pa-
thology.
Numerous studies counter the oxidative stress theory of aging.
Notably, overexpression of MnSOD, which detoxiﬁes O2•-, does not
extend the lifespan of mice [96,97]. This appears at odds with our data
indicating that XJB-5–131 improves the health of Ercc1-/Δ mice. How-
ever, XJB-5–131 is able to both prevent ROS production and neutralize
existing ROS. The nitroxide radical form of XJB-5–131 can be reduced
to a hydroxylamine by accepting an electron from the electron transport
chain and subsequent protonation (Supplemental Fig. 6B), thereby
preventing electron transfer to O2 and resultant ROS production [98].
Hydroxylamines act as robust reducing agents by hydrogen atom
transfer to free radicals and non-radicals such as O=NOO-, resulting in
a signiﬁcant diminution of oxidative/nitrosative stress. While ad-
mittedly, reaction of hydroxylamine with O2•- will result in H2O2 gen-
eration, it will neutralize O=NOO- and by default, this process
Fig. 4. Reduced antioxidant capacity in progeroid Ercc1-/Δ mice and old WT mice. (a) Liver metabolite string analysis of 3-month-old WT (n=6) versus Ercc1−/Δ
mice (n= 7). Metabolites shaded in blue are signiﬁcantly more abundant in the mutant animals. (b) Unbiased diﬀerential proteomic analysis of liver from 5 to 8-
month-old adult WT, 25–30-month-old aged WT and 4-month-old progeroid Ercc1−/Δmice (n= 4–8) revealed a signiﬁcant decrease in the abundance of antioxidant
proteins. (c) Catalase activity in the liver of Ercc1−/Δ and WT mice at various ages (n= 3–5 per group). (d) Cytosolic and (e) mitochondrial superoxide dismutase
(SOD) activity in the liver of Ercc1−/Δ and WT mice at various ages (n= 3 per group). (f) The ratio of oxidized glutathione to reduced glutathione (GSH/GSSG) in
livers from Ercc1−/Δ and WT mice of various ages (n= 3–14 per group). Values represent the mean± SD, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001
determined by one-way ANOVA with Tukey’s test.
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regenerates the nitroxide form of XJB-5–131, thus recycling the radical
scavenger [75]. In contrast, SOD solely reduces O2•- levels, yet gen-
erates H2O2 in the process (2O2•- → H2O2 + O2) which is likely not
well-neutralized in older organisms due to the signiﬁcant reduction in
catalase expression and activity (Fig. 4B-C and Supplemental Fig. 5).
Thus, in the presence of elevated levels of mitochondrial O2•-, over-
expression of MnSOD may yield increased formation of H2O2; an oxi-
dant that is freely diﬀusible and thus capable of mediating oxidative
damage distant from the mitochondrion. This phenomenon has indeed
been reported [99] and the combination of SOD with CAT has been
shown to aﬀord greater protection against Fe2+-induced radical for-
mation than SOD alone [100].
Another argument against the oxidative stress theory of aging is
based on the PolγD257A mice, which age rapidly due to increased mu-
tations in the mitochondrial genome caused by inactivation of the
exonuclease domain of the mitochondrial polymerase γ [101]. Unlike
the progeroid Ercc1−/Δ mice, ROS is not increased in tissues of
PolγD257A mice, countering the notion that oxidative stress drives aging.
However, mutagenesis in the PolγD257A mice is stochastic and there are
thousands of mitochondrial genomes per cell, making it plausible that
phenotypes are less consistent in PolγD257A mice than in Ercc1−/Δ mice
where every cell is aﬀected. Therefore, the lack of increased ROS in
PolγD257A mice was not considered to counter the mitochondrial theory
of aging [101].
In conclusion, we demonstrate that spontaneous, endogenous, nu-
clear DNA damage leads to an accelerated accumulation of senescent
cells in vivo. In addition, we provide novel evidence supporting the
oxidative stress theory of aging. In a mammalian system where spon-
taneous endogenous DNA damage is the primary insult, cellular se-
nescence and ROS abundance is increased, leading to further damage
and senescence. Attenuating mitochondrial-ROS defuses this cycle and
suppresses age-related decline, implicating it as causative. Taken
together, this supports the potential of radical scavengers as a treatment
for age-related co-morbidities.
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